Factors that Influencing Sputum Conversion at the End of Intensive Phase on TB-DM Patients at Medical Health Service in Medan
Abstract
Keywords
Full Text:
PDFReferences
Cahyadi A, Venty. Tuberkulosis Paru pada Pasien Diabetes Melitus. J Indon Med Assoc. 2011; 61(4);173-177.
World Health Organization. Global Tuberculosis Report 2017. Geneva: WHO, 2017: 4-11,115.
Balitbangkes. Riset Kesehatan Dasar. Kementerian Kesehatan. Jakarta. 2013.
Petunjuk Teknis Penemuan TB-DM di FKRTL. Jakarta. 2015.
Guler M, E. Unsal, Dursul B. Factors Influencing Sputum Smear and Culture Conversion Time Among Patients with New Case Pulmonary Tuberculosis. Int. J. Clin. Pract. 61. 2007. 231-235.
Guler M, E. Unsal, Dursul B. Factors Influencing Sputum Smear and Culture Conversion Time Among Patients with New Case Pulmonary Tuberculosis. Int. J. Clin. Pract. 61. 2007. 231-235
Magee MJ, Bloss E, Shin SS, Contreras C, Huaman HA, Ticona JC. Clinical characteristics, drug resistence, and treatmen outcomes among tuberculosis patients with diabetes in Peru. Int J Infect Dis. 2013;17:e404-12.
Kulsum ID, Burhan E, Rochismandoko. Faktor yang Mempengaruhi Konversi Sputum BTA Mikroskopik pada Pasien Tuberkulosis Paru Kasus Baru dengan Diabetes Mellitus. J Respir Indo. 2017;37:1-12.
Wijiyanto A, Burhan E, Nawas A, Rochismandoko,. Pulmonary Tuberculosis in Patients with Diabetes Mellitus Type 2. J Respir Indo. 2015; 35:1-11.
Rekha VB, Balasubramanian R, Swaminathan S, Ramachandran R, Rahman F, Sundaram V. Sputum Conversion at the end of intensive phase of category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: An analysis of risk factors. Indian J Med Res. 2007;126:452-58.
Singla R, Khan N, Al-Sharif N, et al. Influence of Diabetes on Manifestations and Treatment of Pulmonary TB Patients. Int. J. Tuberc. Lung Dis. 10. 2006. 74-79.
Guler M, E. Unsal, Dursul B. Factors Influencing Sputum Smear and Culture Conversion Time Among Patients with New Case Pulmonary Tuberculosis. Int. J. Clin. Pract. 61. 2007. 231-235.
Puspita AK, Yanti Z, Putri PK, Suprianto S, Atiqah N. Redesigning the roles of tuberculosis treatment supporter in Indonesia. Jurnal Administrasi Kesehatan Indonesia, JAKI. 2019::170-177.
Shariff NM, Safian N. Diabetes Mellitus and its Influence on Sputum Smear Positivity at The 2nd Month of Treatment among Pulmonary Tuberculosis Patients in Kuala Lumpur, Malaysia: a Case Control Study. 2015. 324-327.
Cai J, Ma A, Wang Q. et al. Assocoation between body mass index and diabetes mellitus in Tuberculosis Patients in China: a community based cross-sectional study. BMC Public Health. 2017; 17,228.
Olys O, Widjarnako B, Hadisaputro S, Lukmono DT. Faktor Risiko Gagal Konversi Pengobatan Penderita Tuberkulosis Paru fase Intensif(Studi di Kota Bandar Lampung). Jurnal Epidemiologi Kesehatan Komunitas. 2016: 89-95.
Vijay S, Kumar P, Chauhan LS, et al. Risk Factors Associated with Default among New Smear Positive TB Patients Treated Under DOTS in India. PloS One. 2010. 5(4):e10043.1-9.
Jiyani MR, Vadgama PK, Pandey AS, Mohd DA. Clinical Profile and Outcome of Tuberculosis in Patients with Diabetes. Int J Res Med. 2015;4:36-40.
Niazi AK, Kalra S. Diabetes and tuberculosis: a review of the role of optimal glycemic control. J Diabetes Metab Disord. 2012;11.
DOI: https://doi.org/10.30596/bf.v6i2.4767
DOI (PDF): https://doi.org/10.30596/bf.v6i2.4767.g6017
Refbacks
- There are currently no refbacks.
JURNAL BULETIN FARMATERA
Gedung Kampus 1 Universitas Muhammadiyah Sumatera Utara (UMSU) Lantai II, Laboratorium Farmakologi dan Terapi Fakultas Kedokteran UMSU Jalan Gedung Arca No. 53 Medan Sumatera Utara Indonesia, Kode Pos 20217.
Contact (WA): 0812-6208-2844
E-mail: farmatera@umsu.ac.id

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.